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SUMMARY 
The crystallographic model of the enzyme subtilisin 
inhibited with peptide chloromethyl ketones has verified the 
existence of a substrate binding site composed of well-
defined subsites. Based on these findings and the inter­
actions observed, rationalization of previous kinetic data 
on true substrates is possible. However, these rationali­
zations are valid only if the assumption is made that the 
binding of inhibitors in the crystallographic model is a 
good model for substrate binding. Therefore, the purpose 
of this work was to determine the rates of reaction of a 
series of peptide chloromethyl ketones with subtilisin and 
to correlate these rates with the number of interactions 
observed in the crystallographic model and the known 
specificities of the subsites observed from the rates of 
substrate hydrolysis. The positive correlations obtained 
and presented in this thesis provide convincing evidence for 
the postulation that the productive binding for these 
inhibitors which leads to alkylation of His-64 is closely 
related to the productive binding modes of peptide sub­
strates which leads to the acylation of Ser-221. 
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CHAPTER I 
INTRODUCTION 
Subtilisin is a bacterial enzyme discovered by 
Linderstr0n-Lang and Ottesen (1947) during an investigation 
of the conversion of ovalbumin to plakalbumin. This enzyme 
is one member of a widely distributed family of enzymes 
called proteases or proteolytic enzymes which are required 
in biological systems to catalyze the hydrolytic cleavage 
of peptides. Subsequent research showed that there were a 
series of subtilisin proteases exhibiting similar chemical 
properties but varying amino acid composition. The enzyme 
isolated from Bacillus amyloliquefacians, designated 
Subtilisin BPN', has been most extensively studied and in 
this thesis will be referred to simply as subtilisin. Other 
members include Subtilisin Carlsberg, Novo, and Amylosachar-
riticus, but it has recently been shown that the Novo 
enzyme is identical to BPN' in all respects (Kraut, 1971). 
Proteases are divided into four classes (Hartley, 
1960): metallopeptidases, sulfydryl proteases, acid pro­
teases, and serine proteases. The latter group of which 
subtilisin is a member, is classed together due to a common 
functional feature - the presence of a unique, highly 
reactive serine residue at the active site. The reagent 
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diisopropylfluorophosphate (DFP) selectively phosphorylates 
this residue despite the presence of numerous other serine 
residues in the enzyme, and the resulting DIP derivative 
shows no enzymatic activity. Matsubara et al. (1958) 
completely inhibited subtilisin with DFP, crystallized the 
DIP derivative, and showed that one mole of the inhibitor 
was bound to a serine residue per mole of enzyme. Subse­
quently, Noller and Bernhard (1965) used a specific chromo-
phoric acylating agent, furylacryloylimidazole, to label 
and identify the reactive serine of subtilisin. A furyl-
acryl peptide was isolated after enzymatic digestion, and 
a sequence determination showed the labeled residue to be 
Ser-221. 
Another characteristic enzymatic property of serine 
proteases is the presence of a unique histidine residue. 
Oosterbahn and Cohen (1964) provided the first evidence for 
histidine involvement in subtilisin by photooxidation 
studies. Correlation of the loss of a histidine residue 
and enzymatic activity implicated histidine involvement in 
the active site. In addition, kinetic data by Polgar and 
Bender (1967) showed that decreases in subtilisin activity 
was concomitant with protonation of a group with a pK of 
7.2; this group was presumed to be the imidiazole of histi­
dine. Although the above evidence suggested the involvement 
of a histidine residue, direct chemical evidence was lacking. 
Specific reagents used for labeling the active site histidine 
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residue of other serine proteases were unreactive with subt­
ilisin (Smith et a_l. 1966) . However, Shaw and Ruscica (1968) 
were able to synthesize a related active site specific re­
agent which was highly reactive with subtilisin. The new 
reagent, benzyloxycarbonyl-L-phenylalanine bromomethyl ke­
tone (Z-PheC^Br) , was shown to stoichiometrically alkylate 
a single histidine residue, and loss of enzymatic activity 
was demonstrated by the finding that the alkylated deriva­
tive no longer reacted with DFP. Markland et al. (19 68) 
used tritium labeled Z-PheC^Br to identify the reactive 
histidine. After suitable degradation of the labeled enzyme 
by proteolytic hydrolysis and cyanogen bromide cleavage, 
peptides were isolated that were shown to contain histidine 
residue 64 substituted in the three position of the imidazole 
ring. 
From the kinetic and chemical modification studies 
described above, both the histidine residue at position 64 
and the serine residue at position 221 of subtilisin have 
been identified as participating in catalysis even though 
the two residues are remote from one another in the linear 
primary amino acid sequence. It was therefore predicted 
that these residues must come in close proximity in the 
tertiary structure of the enzyme forming part of the cata­
lytic site. High resolution x-ray diffraction studies have 
indeed shown that a hydrogen bond exists between these two 
residues forming part of a hydrogen bond network at the 
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catalytic site (Alden et al.,1970). Contained in this 
network is a hydrogen bond from the OH group of Ser-221 to 
N£2 of His-64; a hydrogen bond from Nel of His-64 to the 
side chain 0<52 of Asp-3 2; and another hydrogen bond which 
extends to 0<$2 of Asp-32 from the side chain OH group of 
Ser-33. All atoms involved in this network (1) lie approx­
imately within the plane of the imidazole ring. This 
network makes possible a charge relay system whereby the 
negative charge on the aspartate residue 32, buried in a 
hydrophobic environment in the enzyme, may be transferred 
to the surface of the molecule at Ser-221. This Ser-221 
exists as a highly nucleophilic alkoxide group in one of 
the canonical forms {2) of the system. This system has also 
been observed in other serine proteases (Birktoft et a_l. , 
1970) . 
The finding that the ultimate site of acylation in 
serine proteases is the hydroxyl oxygen of a unique serine 
residue, led to the hypothesis that enzymatic hydrolysis 
might occur via an intermediate acyl enzyme. However, since 
these results were previously established by chemical analysis 
of the degraded enzyme, it is possible that acylation 
initially occurred elsewhere in the enzyme and was transferred 
to serine during the degradation. Therefore, Bernhard et al. 
(1965), sought to confirm the hypothesis by observing an acyl 
intermediate of subtilisin in solution. Comparison of the 
ultraviolet (uv) spectra of chromophoric acyl enzymes with 
5 
presumed O-acylserine peptide analogues, showed that the 
cinnamoyl- and furylacrylolyl- proteases, isolated at low pH, 
have UV absorption maxima characteristic of an oxygen ester. 
Subsequently, Polgar and Bender (1966) converted the active 
serine of subtilisin into a cysteine residue. Despite 
decreased protease activity, the enzyme was cinnamocylated 
with cinnamoylimidazole and the intermediate showed ultra­
violet absorption maxima characteristic of a thiol ester. 
These results supported the hypothesis that peptide bond 
cleavage might occur via a two step process involving acyla-
tion and deacylation. A possible mechanism incorporating 
these results has been proposed and is illustrated below 
(Blow et al^ . , 1969) . Following binding of the substrate to 
the enzyme forming the enzyme-substrate couplex (3) , the 
carbonyl carbon of the substrate is attacked by the serine 
oxygen forming the acyl enzyme (4). Deacylation of this 
intermediate is presumed to be the exact reverse of the 
acylation step, except with water in the position formerly 
occupied by the leaving group (5). Thus, the enzyme is 
restored to its active form for further catalysis (6). The 
crystallographic model of the active site of subtilisin is 
shown in Figure 1. 
As previously mentioned, enzymes exhibit substrate 
specificity primarily in the types of chemical bonds that 
they cleave and are often classed accordingly. A variety 
of large proteins have been hydrolyzed by subtilisin 
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Figure 1 . Crystallographic Model of the Active Site of 
Subtilisin. 
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including casein, hemoglobin, gelatin, oxidized lysozyme, 
and insulin (Okunuki et a_l., 1956; Tuppy, 1953). In each 
case, the enzyme cleaved not only at internal peptide bonds 
but also at terminal bonds yielding free amino acids. Due 
to this activity on peptide bonds subtilisin was classed as 
a protease and more specifically as an endopeptidase, 
splitting peptide linkages at any point in a peptide chain 
(as opposed to an exopeptidase which can split only terminal 
peptide bonds). In addition to being a protease, subtilisin 
was also shown to have esterase activity, hydrolyzing small 
synthetic esters (Matsubara et al., 19 58). From many early 
studies, however, it has been determined that enzymes exhibit 
not only primary specificity for a particular chemical bond, 
but also a secondary specificity for another functional 
group (or groups) in the substrate essential for its binding 
to the enzyme such that the sensitive bond is properly 
oriented with respect to the catalytic groups (Lehninger, 
1970) . Consequently, subtilisin would be expected to cleave 
peptide bonds in proteins, but not indiscriminately. Mori-
hara and Tsuzuki (1969) reinvestigated the subtilisin cata­
lysed cleavage of insulin under restricted conditions and 
found secondary specificity in its discriminate cleavage 
at the carbonyl group of amino acid residues with aromatic 
or apolar side chains. These observations were consistent 
with the subsequent finding of these authors that hydrolysis 
of small amide and ester substrates such as CBZ-Gly-X-NH-
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and acetyl-X-ethyl ester occurred at the carbonyl-terminal 
side of residue X, where X represented such residues as L-
tyrosine, L-phenylalanine, and L-leucine. To further study 
these secondary specificities, Morihara et al. (19 69) syn­
thesized a series of oligopeptides and examined the effect 
of neighboring residues surronding the sensitive linkage. 
An acceleration in the rate of hydrolysis was observed when 
the peptide chain was elongated on the N-terminal side of 
the point of catalytic cleavage: CBZ-Leu-NH 0 (0.23) CBZ-
Gly-Leu-NH 2 (1) CBZ-Gly-Gly-Leu-NH 2 (36.1) (the arrow 
indicates the point of cleavage and the numbers in paren­
theses are relative rates of hydrolysis). It was also 
found that hydrolysis is inhibited when the terminal a-amino 
and ^-carbonyl groups of these substrates were unblocked, 
if the former group within four residues on the N-terminal 
side and the latter group within one residue on the C-terminal 
side of the cleavage point. Thus, it is postulated that the 
active site of subtilisin, and other serine proteases is 
composed of two specific zones. One is the catalytic zone 
(or catalytic site) composed of the residues in the enzyme 
immediately responsible for bond breaking, and the second 
is a binding site where the substrate is bound to the 
enzyme. The binding site appears to be composed of a 
sequence of subsites. A scheme for depicting the position­
ing of a polypeptide chain in the binding site of a protease 
has been proposed (Schecter and Berger, 19 67) and is shown 
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in Figure 2. 
Morihara et al. (1970) found that in subtilisin each 
subsite exhibits individual stereo- and side chain speci­
ficities. Stereospecificity was exemplified by the fact 
that the site of hydrolysis of polypeptide amides was greatly 
reduced when D-amino acid residues were substituted for the 
corresponding diasterioisomers. In fact, a distinct pref­
erence was shown for L-amino acids at all subsites. Hydrol­
ysis rates also showed dependence on the particular side 
chain at a given subsite; for example, alanine at S 2 greatly 
promoted activity when compared with glycine, histidine, or 
tyrosine. 
To account for the aforementioned specificities and 
to determine the specific interactions occurring at the 
individual subsite, crystallographic structures of substrates 
actually bound to the enzyme must be observed. However, 
enzymatic reactions occur on a time scale in the neighbor-
-3 
hood of 10 seconds or faster and collection of adequate 
x-ray data requires days. Robertus et al. (1971) circum­
vented this problem by the use of irreversible covalent 
inhibitors believed to be analogues of good polypeptide 
substrates. Four polypeptide chloromethyl ketone inhibitors 
with an L-phenylalanine residue at their C-termini were 
bound to subtilisin and investigated. All were found to 
alkylate the catalytic site His-64 at N^2 with their phenyl­
alanine side chain fitting into a hydrophobic crevice. The 
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Figure 2. Scheme for Depicting the Positioning of a 
Polypeptide Chain in the Binding Site of a 
Protease. (Schecter and Berger, 1967) 
Amino acid residues P^, P 2, Pj_ and P 1 are located at 
subsites Sg, S 2 , S 1 and S 1 , respectively. Side chains 
are designated by R. Cleavage occurs between residues 
P 1 and P 1 . Additional subsites exist at either end, 
X or Y. 
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polypeptide chain of each inhibitor was extended and bound 
in the manner of an antiparallel $-sheet to a segment of 
extended backbone chain in the enzyme consisting of Ser-125 -
Leu-126 - Gly-127. A detailed description of the inter­
action at each subsite was obtained. These interactions 
and the mode of binding are illustrated in Figure 3 and 
will be described briefly. 
At subsite S^f the phenylalanine side chain of P 1 lies 
in a crevice formed by three pieces of the enzyme molecule. 
Two sides of the crevice are flat and well-defined, but the 
third is less regular. A flat face of the crevice consists 
of the extended backbone of segment Ser-125 - Leu-126 - Gly-
127. A second interaction at S 1 is a hydrogen bond between 
the NH of P 1 and the carbonyl oxygen of Ser-125. 
Interactions at S 2 are less well-defined. The NH 
and CO of P 2 point toward the solvent, but interaction of 
the side chain with residues in the enzyme appears likely. 
Interactions between P 3 and S 3 are again quite well-
defined. Hydrogen bonds are possible between the CO of P 3 
and the backbone NH of Gly-127, and between the NH of P 3 
and the backbone CO of Gly-127. The side chain of P 3 appears 
not to interact with subsite S 3 . 
The nature of the possible interactions at S 4 was not 
observable since only tripeptide inhibitors were studied. 
From the crystallographic model of the inhibited 
enzyme, the existence of a binding site composed of well-
C H — 0 — 
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Figure 3 . Mode of Binding Peptide Chloromethyl 
Ketone Inhibitors to Subtilisin. 
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defined subsites has been verified. Based on the findings 
and the interactions observed, rationalization of previous 
kinetic data on true substrates is possible. However, these 
rationalizations are valid only if the assumption is made 
that the binding of inhibitors in the crystallographic model 
is a good model for substrate binding. Therefore, the 
purpose of the work presented in this thesis was to determine 
the rates of reaction of a series of peptide chloromethyl 
ketones with subtilisin and to correlate these rates with 
the number of interactions observed in the crystallographic 
model and the known specificities of the subsites observed 
from the rates of substrate hydrolysis. Positive correla­
tions would provide convincing evidence for the postulation 
that the productive binding mode for these inhibitors which 
leads to alkylation of His-64 is closely related to the 
productive binding modes of peptide substrates which leads 
to the acylation of Ser-221. A second objective was to 
synthesize a tetrapeptide leucine chloromethyl ketone for 
future crystallographic studies of the binding interactions 
at the fourth and first subsites respectively. 
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CHAPTER II 
EXPERIMENTAL 
Methods and Materials 
The following reagents were obtained from commercial 
sources: optically active amino acids from Ajinomoto Co., 
Inc., Japan (all amino acids used were of the L form unless 
otherwise stated); glycylglycine from Pierce Chemical Co.; 
benzylchloroformate and tert-butyl azidoformate from PCR, 
Inc.; i-butyl chloroformate and i-valeryl chloride from 
Eastman Chemical Co.; N-ethoxycarbonyl-2-ethoxy-l,2-di-
hydroquinoline (EEDQ) from Aldrich Chemical Co.; and 
Subtilisin BPN 1 from Nagase and Co., Japan (used without 
further purification). 
The enzyme substrate N-acetyl-L-tyrosine ethyl ester 
monohydrate was synthesized in the laboratory by standard 
methods and recrystallized from ethanol-water to constant 
melting point (79.5°-80.5°). Anhydrous magnesium sulfate 
was employed in drying organic solutions and extracts in 
organic solvents. 
Tetrahydrofuran (THF) was dried by refluxing 24 hours 
over sodium metal and then distilling from benzophenone 
ketyl. Dimethylformamide (DMF) was dried for 48 hours over 
4A molecular sieves. Anhydrous N-methyl morpholine was 
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obtained by distillation from potassium hydroxide pellets. 
All other common chemicals and solvents were analytical 
grade. 
Mass spectra were obtained using a Varian Model A-66 
medium resolution mass spectrometer. Nuclear magnetic 
resonance (nmr) spectra were acquired using a Varian Model 
A-60 spectrometer; solvents used were deuterochloroform 
( C D C I 3 ) and deuterodimethylsulfoxide (DMSO-d^) containing 
one percent tetramethylsilane (TMS) as an internal standard, 
or deuterium oxide containing sodium 2,2-dimethyl-2-silapen-
tane-5-sulfonate (DSS) as an internal standard. 
Solvent evaporation under reduced pressure was accom­
plished with a Buchler flash evaporator. Melting points 
were determined using a Buchi capillary melting point appa­
ratus and are uncorrected. Elemental microanalyses were 
performed by Atlantic Microlab, Inc., Atlanta, Georgia. 
All compounds isolated were shown to be pure by thin-
layer chromatography. The absorbent used was silica gel G, 
pre-coated (Merck) on glass plates. After development in 
the appropriate solvent, the spots were detected in a closed 
chamber saturated with iodine vapor. 
Peptide chloromethyl ketones in addition to those 
described in the experimental section were used for kinetic 
studies. These were previously prepared as described by 
Powers and Wilcox (1970) and Segal et al. (1971). 
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Experimental Procedures 
Preparation of Inhibitors 
Acetylglycylglycyl-L-alanine Benzyl Ester (Ac-Gly-
Gly-Ala-OBzl). The p-toluenesulfonic acid salt of L-alanine 
benzyl ester was prepared by the azeotropic distillation of 
L-alanine, p-toluenesulfonic acid, benzyl alcohol, and 
benzene (Greenstein et al., 1961) and neutralized in cold 
sodium carbonate. Following extraction with ether and con­
centration under vacuum, the liquid L-alanine benzyl ester 
was obtained. A solution of Ac-Gly-Gly-OH (6.0 g, 34.5 
mmoles; prepared by acylation of glycylglycine with one 
equivalent of acetic anhydride in boiling glacial acetic 
acid) in DMF (150 ml) was cooled in a moisture-free reaction 
vessel to -15°C with a dry ice-acetone bath. While stirring, 
N-methylmorpholine (3.79 ml, 34.5 mmoles) was added to the 
solution followed by isovaleryl chloride (4.16 g, 34.5 
mmoles). A precipitate immediately formed and the reaction 
mixture was allowed to stir ten minutes. Alanine benzyl 
ester (6.17 g, 34.5 mmoles) was added and the flask allowed 
to come to room temperature. The N-methylmorpholine hydro­
chloride was filtered off, and the filtrate was concentrated 
under vacuum giving a yellow residue. The residue was washed 
with two 25 ml portions of water giving immediate crystalli­
zation of the product. The product was recrystallized from 
hot methanol yielding 6.92 g (60%): mp 191-192°; nmr (DMSO-dg) 
showed signals at 6 1.32 (3H, d, alanine methyl), 1.88 (3H, 
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s, acetyl), 5.13 (2H, s, CgH^CH^-) , 7.35 (5H, s, C gH 5-) ; 
mass spectrum m/e (relative intensity) 263 (7, P-CH 3CONHCH 2), 
221 (5), 149 (9), 128 (66, NHC^CONHCH (CH^) CO) , 107 (16, 
C 6 H 5 C H 2 0 ) ' 9 1 ( 1 0 0 ' C 6 H 5 C H 2 ) ' 8 5 ( 2 8 ' C O C H ( C H 3 ) N H C O ) , 57 (50, 
NHCH 2CO). 
Anal. Calcd for c 1 6 H 2 i N 3 ° 5 : C ' 57.31; H, 6.26; N, 
12.53. Found: C, 57.34; H, 6.40; N, 12.61. 
The above compound was also obtained by activation of 
Ac-Gly-Gly-OH (4.25 g, 24.4 mmoles) with EEDQ (6.18 g, 25 
mmoles) in DMF (200 ml). Alanine benzyl ester (4.37 g, 
24.4 mmoles) was added, and the solution was stirred for 30 
hours at room temperature. The solvent was removed in vacuo 
giving a yellow residue. Upon washing with chloroform, the 
yellow color was lost and white crystalline product remained. 
The product was recrystallized as above yielding 3.62 g (44%). 
Acetylglycylglycyl-L-alanine (Ac-Gly-Gly-Ala-OH). 
A suspension of Ac-Gly-Gly-Ala-OBzl (1.6 g, 5.0 mmoles) and 
10 percent palladium on charcoal (0.3 g) in acetic acid 
(150 ml) was hydrogenated on a Paar bomb under 40 psi pressure. 
After two hours, the catalyst was filtered off, and the fil­
trate evaporated in vacuo to give white crystalline product. 
The product was recrystallized from ethanol-ether to yield 
1.10 g (90%): mp 197-199°; nmr (D 20) showed signals at <5 
1.42 (3H, d, alanine methyl), 2.08 (3H, s, acetyl), 4.00 
(4H, s, glycine methylenes); mass spectrum m/e (relative 
intensity) 220 (13), 205 (53), 149 (53), 110 (100), 73 (80, 
21 
CH 3CHCOOH), 57 (53, NHCH 2CO), 43 (86, CR^CO). 
Acetylglycylglycyl-L-alanyl-L-phenylalanyl Chloro­
methyl Ketone (Ac-Gly-Gly-Ala-PheCH^Cl). The mixed anhydride 
formed from Ac-Gly-Gly-Ala-OH (1.0 g, 4.0 mmoles), N-methyl­
morpholine (.44 ml, 4.0 mmoles), and i-butylchloroformate 
(.52 ml, 4.0 mmoles) in DMF (30 ml) was reacted with L-
phenylalanine chloromethyl ketone hydrobromide (Segal et al., 
1971) and triethylamine (.67 ml, 4.5 mmoles) for two hours. 
The DMF was removed under vacuum and 10 ml of chloroform was 
added to the residue giving immediate crystallization of the 
product. The product was filtered and successively washed 
with 1 M citric acid, 10% sodium bicarbonate, and distilled 
water. The resulting crystals were recrystallized from 
methanol-water yielding .92 g (54%): mp 222-224°; nmr (DMSO-
dg) showed signals at 6 1.14 (3H, d, alanine methyl), 1.88 
(3H, s, acetyl), 3.08 (2H, d, CgH^CH^-) , 3.66-3.81 (4H, m, 
glycine methylenes), 4.50 (2H, d, -CH 2-C1), 7.26 (5H, s, 
CgH^-); mass spectrum m/e (relative intensity) 424 (2, P ) , 
360 (4, P-CH 2C1 + C H 3 ) , 317 (4, 360-CR"2CO) , 200 (12, 
CH 3CONHCH 2CONHCH 2CONHCHCH 3), 180 (18, C 6H 5CH=CHC0CH 2C1), 
129 (13, CH 3CONHCH 2CONHCH 2) , 91 (36, CgR^CR^) , 72 (74, 
CH 3CONHCH 2), 43 (100, CR^CO). 
Anal. Calcd for C 1 9 H 2 5 C 1 N 4 0 5 : C ' 5 3- 6 4/' H , 5.88; 
N, 13.17; CI, 8.47. Found: C, 53.58; H, 5.92; N, 13.09; 
CI, 8.50. 
N-Benzyloxycarbonyl-L-leucyl Chloromethyl Ketone 
22 
(Z-LeuCH 2Cl). A solution of Z-Leu-OH (3.3 g, 12.5 mmoles; 
prepared by the method of Schotten and Bauman from L-leucine, 
benzyloxycarbonyl chloride, and sodium hydroxide) was dis­
solved in THF (60 ml) and added to a reaction vessel over a 
fritted filter which was kept at a temperature of -5°C by a 
constant temperature circulator. While stirring, N-methyl-
morpholine (1.38 ml, 12.5 mmoles) was added, followed by 
i-butylchloroformate (1.63 ml, 12.5 mmoles). A white pre­
cipitate immediately formed; the mixture was stirred for 15 
minutes and then filtered into a moisture-free flask. To 
the filtrate was added 25 millimoles of diazomethane in 
ether (Moore and Reed, 1961). After standing in the refrig­
erator overnight, the solution was saturated with HCI gas. 
The solvents were removed under vacuum giving a yellow oil. 
The oil was taken up in ethyl acetate and successively 
washed with 1 M citric acid, 10% sodium carbonate, and 
distilled water. After drying and removal of the solvent, 
2 . 5 g (69%) of product was obtained as an oil: nmr (CDC1 3) 
showed signals at 6 .91 (6H, d, isopropyl), 4.21 (2H, s, 
CH 2C1), 5.08 (2H, s, C 6 H 5 - C H 2 - ) , 7.30 (5H, s, C g H ^ ; mass 
spectrum m/e (relative intensity) 261 (2, P-HC1), 220 (27, 
P - C 6 H 5 ) , 219 (9, C 6H 5CH 2OCONHCH(CH 2)COCH 2), 205 (2, 219-CH 2), 
151 (4, P-(CH 3) 2CHCH=CHC0CH 2C1), 111 (2, (CH 3) 2CHCH=COCH 2), 
107 (23, C 6H 5CH 20) , 91 (100, CgHj-CHj) , 77 (29, CgH^ , 57 (32, 
CH 2CH(CH 3) 2 ) , 43 (32, CH(CH 3) 2). 
L-Leucyl Chloromethyl Ketone Hydrochloride (LeuCH 2Cl-
23 
HCI). The monohydrate of BOC-Leu-OH was prepared from L-
leucine, tert-butyl azidoformate, and sodium hydroxide in 
dioxane and water (Schnabel, 1967). The crystalline mono-
hydrate was taken up in ethyl acetate and dried over magnes­
ium sulfate. After filtration and removal of the solvent, 
a clear oil was obtained. The chloroketone of BOC-Leu-OH 
was prepared by a procedure analogous to that used to pre­
pare Z-LeuCH2Cl. However, upon saturation of the intermedi­
ate diazoketone with hydrogen chloride, the tert-butyloxy-
carbonyl group was removed with simultaneous formation of 
the chloroketone giving crystalline L-leucine chloromethyl 
ketone hydrochloride. Following filtration, the crystalline 
product was obtained in 71% yield: mp 150-151°. 
Acetyl-L-alanyl-L-leucyl Chloromethyl Ketone (Ac-Ala-
LeuCH^Cl). Acylation of L-alanine was carried out in boil­
ing acetic acid with one equivalent of acetic anhydride. 
N-Acetyl-L-alanine was coupled with L-leucine chloromethyl 
ketone hydrobromide via the mixed anhydride procedure pre­
viously described. The crude oil obtained was placed on a 
chromatography column of 0.05-0.02 mm Silica Gel G and the 
product was eluted with 4% methanol in chloroform. Crystall­
ization from ethyl acetate-petroleum ether gave 14% yield: 
mp 95-98°; nmr (CDC1 3) showed signals at 6 1.04 (6H, d, iso­
propyl) , 1.45 (3H, d, alanine methyl), 2.08 (3H, s, acetyl), 
4.33 (2H, s, -CH 2C1); mass spectrum m/e (relative intensity) 
261 (4, P-CH 3), 199 (40, P-COCH 2Cl), 114 (25, CH 3CONHCH(CH 3) 
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CO), 86 (100, CH 3CONHCHCH 3), 43 (16, CR^CO). 
Anal. Calcd for C 1 2 H 2 1 C 1 N 2 0 3 : C, 52.17; H, 7.61; 
N, 10.14. Found: C, 52.34; H, 7.40; N, 10.01. 
N-t-Butyloxycarbonyl-glycylglycyl-L-leucyl Chloro­
methyl Ketone (Z-Gly-Gly-LeuCH^Cl). This compound was pre­
pared from Z-Gly-Gly-OH (1.34 g, 5.03 mmoles; prepared from 
glycylglycine and benzyloxycarbonyl chloride) by a mixed 
anhydride procedure as previously described. The crude 
product obtained as an oil was chromatographed on 0.05-0.02 
mm Silica Gel G (elution with 4% methanol). Crystallization 
occurred from ethanol-water; however, when any attempt was 
made to filter and isolate the crystalline product an oil 
was obtained. Attempts at crystallization with other 
solvents indicated that water must be present in order for 
the crystal structure to form and remain in tact. Therefore, 
all solvents were removed in vacuo and the product was iso­
lated as an oil (34% yield): nmr (CDC1 3) showed signals at 
<5 .94 (6H, d, isopropyl), 3.90 (4H, t, glycine methylenes), 
4.26 (2H, s, -CH 2-C1), 5.08 (2H, s, CgR^-CH^-), 7.30 (5H, s, 
CgH^-); mass spectrum m/e (relative intensity) 345 (1, P-
2CH 3-HC1), 271 (82, P-C 6H 5CH 2-CH 2C1) , 255 (12, P - C ^ C R ^ O -
CH 2C1), 197 (13, CONHCH 2CONHCH 2CONHCHCO), 193 (100), 135 
(23, C 6 H 5 C H 2 O C O ) , 107 (6, C 6 H 5 C H 2 0 ) , 85 (19, (CH 3) 2CHCH 2CHNH), 
43 (55, CH(CH 3) 2) . 
Anal. Calcd for C 1 9 H 2 6 N 3 ° 5 C 1 : C ' 5 5- 4 0'* H ' 6 « 3 1 ? 
N, 10.20. Found: C, 54.14; H, 6.65; N, 10.01. 
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Acetyl-L-phenylalanyl-glycylglycine Ethyl Ester (Ac-
Phe-Gly-Gly-OEt). A mixed carboxylic anhydride was prepared 
from Ac-Phe-OH (4.14 g, .02 moles; prepared by acylation of 
L-phenylalanine with acetic anhydride in boiling acetic acid), 
isobutylchloroformate (2.6 ml, .02 moles), and N-methyl 
morpholine (2.2 ml, .02 moles) with DMF (25 ml) as the sol­
vent. To this solution was added glycylglycine ethyl ester 
hydrochloride (3.92 g, .02 moles, prepared by reaction of 
glycylglycine in absolute ethanol with HCI gas; Greenstein, 
1961) and triethylamine (3.0 ml, .02 moles). Following the 
standard work-up as described above, the product was isolated 
and recrystallized from hot chloroform yielding 2.4 g (38%): 
mp 150-151°; nmr (DMSO-dg) showed signals at 6 1.20 (3H, t, 
-CH 2-CH 3) , 1.75 (3H, s, acetyl), 2.90 (2H, d, C ^ - C H J , 
4.10 (4H, m, glycine methylene), 7.26 (5H, s, CgH^-); mass 
spectrum m/e (relative intensity) 349 (8, P ) , 304 (6, P-
C H 3 C H 2 0 ) , 290 (39, C 6H 5CH=CHCONHCH 2CONHCH 2COCH 2CH 3), 247 
(50, CH 3CONHCH(CH 2C 6H 5)CONHCH 2CO), 199 (93, CH 3C0NHCH(CH 2) 
CONHCH 2CONHCH 2), 131 (58, C 6H 5CH=CHCO), 120 (100, C 6 H 5 C H 2 
CHNH) r 104 (49, C 6 H 5 C H 2 C H ) , 91 (49, C g H 5 C H 2 ) . 
Anal. Calcd for C 1 7 H 2 3 N 3 0 5 : C ' 5 8 - 4 5 ? H / 6.59; N, 
12.03. Found: C, 58.27; H, 6.69; N, 11.88. 
Acetyl-L-phenylalanyl-glycylglycine (Ac-Phe-Gly-Gly-
QH. A suspension of Ac-Phe-Gly-Gly-OEt (1.5 g, 4.3 mmoles) 
in 20 ml of .25 N NaOH was stirred vigorously for 3 hours 
at room temperature. The ester gradually dissolved and the 
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solution was extracted with two 25 ml portions of ethyl 
acetate. After acidification with HC1 to pH 1-2, the water 
was removed in vacuo to give a white glassy residue. The 
residue was washed with methanol and filtered. After removal 
of the methanol, the acid was isolated (not crystallized) 
and is to be used in the synthesis of Ac-Phe-Gly-Gly-PheCR^Cl 
or Ac-Phe-Gly-Gly-LeuCH 2Cl. 
Reaction of Subtilisin with Inhibitors 
All inhibition experiments were carried out at 30.0°C 
and at pH 7.0. Stock solutions of the inhibitors were pre­
pared at the appropriate concentrations in dimethoxyethane 
(DME). The inhibition was started by diluting 0.2 ml of 
inhibitor solution up to 2.0 ml with 0.1 M phosphate buffer 
and adding 0.2 ml of subtilisin (contained in pH 7 buffer). 
— 6 
The final concentration of enzyme was 5 x 10 M and of DME 
9 percent. Control experiments showed that this amount of 
DME did not cause significant change in the specific activity 
of subtilisin over the time periods of inhibition. Inhibi­
tor concentrations were varied to obtain measurable reaction 
rates; concentrations were reduced in the case of Z-Gly-Leu-
PheCH 2Cl and BOC-Gly-Leu-PheCH 2Cl due to low solubilities 
of these compounds. 
At various time intervals, an aliquot (100 ul) was 
removed from the inhibition mixture and assayed for residual 
enzyme activity using N-acetyl-L-tyrosine ethyl ester (Ac-
Tyr-OEt). With Ac-Tyr-OEt as substrate, the assay mixtures 
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contained 0.11 M substrate in 0.1 M KC1 containing 8% THF 
by volume. Titration was performed at pH 7.8 and 30° with 
.048 N base. The initial velocity was obtained from the 
slope of the plot of base against time consumption. The 
pH-stat used was composed of a Radiometer Titrator Type TT 
lib, pH Meter Type PHM 26c, Autoburette Type ABU 13, and 
Recorder Type SBR 2c. 
Under the conditions of the assay, the rate of Ac-
Tyr-OEt hydrolysis was directly proportional to enzyme con­
centration. Values of K Q B S for each inhibition experiment 
were calculated from the equation In V = ~ KoBS t + c o n s t a n t 
using V and t as input into a Univac 1108 computer operating 
on a least squares program. The initial rate of substrate 
hydrolysis at time t is represented by V. 
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CHAPTER III 
RESULTS 
Inhibition of subtilisin with a series of peptide 
chloromethyl ketones was followed as a function of time 
through at least two half lives. Good pseudo first order 
kinetics were observed in all cases, and the pseudo first 
order rate constant ( K 0 Bg) w a s measured from the rate of 
decrease of residual enzyme activity in the inhibition 
mixture. A least squares analysis of the data points for 
each inhibition gave correlation coefficients greater than 
.95. In Table I the results at 30°, pH 7.0, and 9% 1,2-
dimethoxyethane (DME) are shown. Methanol (9%) was used in 
the case of Ac-Gly-Gly-Ala-PheCH2Cl due to its low solubil­
ity in DME. Comparison of the rate of hydrolysis of Ac-Tyr-
OEt in the presence of 9% DME and 9% methanol showed that 
the activity of subtilisin was essentially the same in 
either solvent. 
Enzyme solutions were prepared fresh each day in 0.1 
M phosphate buffer (pH 7.0) to prevent loss of activity from 
autolysis due to standing in solution overnight. The enzyme 
concentration varied slightly for individual inhibitions 
— 6 
in the range of 5.0 to 5.4 x 10 M. 
Table 1. Data from the Inhibition of Subtilisin with Chloromethyl Ketones. 
T:30°C; pH 7.0; 9% DME; [E] 5 x 1Q-6. 
[I] K OBS 
Relative 
Rates 
Ac-Ala-PheCH 2Cl 
Ac-Gly-PheCH 2Cl 
Ac-Leu-PheCH 2Cl 
Ac-Ala-LeuCH 2Cl 
Z-Gly-Gly-PheCH 2Cl 
Z-Gly-Gly-LeuCH 2Cl 
1.4x10 
1.4x10 
1.4x10 
1.4x10 
1.5x10 
1.5x10 
1.5x10 
1.5x10 
2.5x10 
6.9x10 
6.9x10 
BOC-Gly-Leu-PheCH 2Cl 2.5x10 
2.5x10 
-3 
-3 
-3 
-3 
-3 
-3 
-3 
-3 
-4 
-5 
-5 
-4 
-4 
4.92x10 
5.08x10 
3.70x10 
3.45x10 
5.30x10 
5.77x10 
-4 
-4 
-5 
-5 
-5 
-5 
9.33x10 
1.00x10 
2.6x10 
1.09x10 
1.20x10 
5.86x10 
5.00x10 
-4 
-3 
-3 
-3 
-3 
-4 
-4 
3.51x10 
3.60x10 
2.64x10 
2.46x10 
3.53x10 
3.84x10 
6.22x10 
6.71x10 
10.60 
15.84 
17.39 
2.34 
2.01 
-1 
-1 
13.92 
-2 
-2 
-2 
-2 
-1 
-1 
1.00 
1.44 
25.33 
415.68 
651.37 
85.09 
a BOC-Ala-Gly-PheCH 2Cl 2.49xl0" 4 
2.49xl0" 4 
a 
Z-Gly-Leu-PheCH 2Cl 1.2xl0~ 4 
1.2xl0' 4 
a 
Ac-Ala-Gly-PheCH 2Cl 2.49xl0' 4 
d 
Ac-Gly-Gly-Ala-PheCH 2Cl 2.50xl0~ 4 
a 
Ac-Ala-Ala-Pro-AlaCH 2Cl 2.70xl0" 4 
a
 5xl0" 6 [E] 
b
 5.4xl0" 6 [E] 
C
 5.6xl0" 6 [E] 
d
 5.8xl0" 6 [E] 
2.55xl0" 3 10.25 
2.97xl0""3 11.94 
4.22xl0" 4 3.35 
4.37xl0" 4 3.47 
434.90 
133.72 
1.07xl0" 3 4.30 168.62 
2.10xl0" 3 8.78 344.31 
1.63xl0" 3 6.05 237.25 
u> 
o 
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Kinetics of Inactivation 
A simple bimolecular reaction between an enzyme and 
inhibitor may be represented by the chemical equation 
K 
E + I E - I 
and the second order rate equation for this reaction is 
given by 
V = ^ - = - ^ - = K2(E] m a) 
However, under the special conditions when the inhibitor 
concentration is much greater than the enzyme concentration, 
[I] is essentially unchanging and equation (1) reduces to 
equation (2). 
v
 = - a^r- = KOBS ™ <2> 
or in the integrated form 
In [E]/[E o] = - K 0 B S t (3) 
where [E] is the enzyme concentration at time t, [E q] is 
the initial enzyme concentration at time 0, and K Q B g is the 
experimentally determined rate constant obtained from the 
Ac-Tyr-OEt assay of residual enzyme activity in the inhibi­
tion mixture at specified time intervals. Thus, when [I] >> 
[E Q], the reaction is bimolecular, but exhibits pseudo 
first order kinetics with the observed first order rate 
constant (K-.o0, in dimensions of reciprocal time) equal to 
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the true second order rate constant multiplied by the in­
hibitor concentration (equation 4 ) . 
K O B S = K2m (4) 
If both sides of equation (4) are divided by [I], K 0 B S / [ I ] 
has the dimensions of concentration - 1 time - 1 and is equal 
to the second order rate constant (equation 5 ) . 
KOBS 
= K . (5) 
[I] ^ 
The kinetic equations described above are generally 
applicable to enzyme catalyzed reactions. However, the 
kinetics of inhibition of certain enzymes by irreversible 
inhibitors reveals the presence of a reversible enzyme-
inhibitor complex preceeding covalent bond formation. 
Evidence for this behavior has been demonstrated in the 
inhibition of cholinesterase by certain methanesulfonic acid 
esters (Kitz and Wilson, 1962), trypsin by Tos-LysCH 2Cl 
(Shaw and Glover, 1970), carboxypeptidase A by N-ethyl-5-
phenylisooxazolium-3'-sulfonate (Petra, 1971), and chymo-
trypsin by MeS0 2-DL-PheCH 2Cl (Kumar and Hein, 197 0). Con­
clusive evidence has not been obtained to show that inhibi­
tion of subtilisin by peptide chloromethyl ketones occurs 
via an intermediate complex. However, the finding that 
subtilisin will not react with Tos-PheCH 2Cl (Smith et al., 
1966) but will react with Z-PheCH 2Cl (Morihara and Oka, 1970) 
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and Z-PheCI^Br (Shaw and Ruscica, 1968) seems to indicate 
that prior to covalent bond formation a prerequisite enzyme-
inhibitor complex is formed and the inhibitor must be 
structured so that binding to the enzyme is favorable. 
Consequently, experimentally determined K Q B S values must be 
related to the kinetic parameters associated with an inter­
mediate complex. 
The irreversible reaction of an active site directed 
inhibitor involving an intermediate complex may be represented 
by the overall reaction sequence 
k l k 
E + I E-I ^ E - I 
where E»I is the reversible noncovalently bound complex of 
the enzyme with the inhibitor and E-I represents the inactive 
enzyme with inhibitor irreversibly bound via a covalent 
linkage. The following equations apply: 
[E°] = [E] + [E-I] (6) 
where [E°] is the initial concentration of enzyme and at any 
time is equal to all species involving enzyme in this inhibi­
tor solution; and 
[E] = [E] + [E-I] (7) 
where [E] is the concentration of free and noncovalently 
bound enzyme. Since k^ is the limiting rate of inactivation. 
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the dissociation constant of the E«I complex may be defined 
as 
K i = k 2 / k : L = [E] [I]/[E-I] (8) 
Substituting [E] = [E] - [E«I] from equation (7) into equation 
(8) and solving for [E*I] gives equation (9). 
If the inhibitor concentration is sufficiently greater than 
the total enzyme concentration, the decrease in [#] in the 
inhibition mixture is dependent on the concentration of the 
enzyme inhibitor complex, 
" ^ f 1 = k 3 [ E * I ] ( 1 0 > 
The concentration of both free and noncovalently bound 
enzyme represented by [E] is measured by the assay due to 
the dilution of the reversible enzyme inhibitor complex in 
the assay mixture. 
Substitution of equation (9) into equation (10) gives 
"
 =
 k 3 [ ^ ] [ 1 3 / K j + I i ] (11) 
and rearranging (Kitz and Wilson, 1962). 
_ d[g] _ , 1 . . 
^ t ~ " k 3 ( 1 2 ) 
Since [I] is essentially constant, equation (12) may be in­
tegrated to give equation (13). 
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In [E]/[E°] = -k 3t K (13) 
Equation (13) is related to the pseudo first order rate 
constant ( K 0 Bg) in equation (3). Thus, 
-
KOBS t = -v vinti ( 1 4 ) 
which reduces to 
k 3 
KOBS " Kj/tll+l ( 1 5 ) 
This equation may be expressed in its reciprocal form (equa­
tion 16) . 
1_ = K I + 1 (16) 
KOBS k 3 [ I J ^3 
This derivation shows that the decrease in free enzyme 
concentration [E] in the inhibition mixture follows pseudo 
first order kinetics at any fixed value of [I] if [I] [E] 
and the observed first order rate constant is represented 
by equation (15) or its reciprocal form, equation (16). 
Therefore, in general K Q B S is not constant with changing 
values of [I] , and the exact meaning of depends upon 
the relative magnitude of the inhibition concentration and 
the binding constant (Kj) of the enzyme-inhibitor complex. 
If [I] = K J r equation (l5) defines K 0 B S ' a n d K I a n d k 3 m a ^ 
be evaluated by use of a double reciprocal plot and equation 
(16). If [I] >> Kj, equation (15) reduces to 
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K OBS (17) 
and the K OBS is a measure of the rate of covalent bond for­
mation in the enzyme-inhibitor complex. If [I] << K 
equation (15) reduces to 
TTT 
OBS (18) 
and the second order rate constant K Q B S / [ I ] reflects both 
the influence of K-j. and k^. 
Since inhibitor binding constants cannot be obtained 
from the data presented in Table I, the specific equation 
Glazer (1967) measured Kj's for a series of competitive 
inhibitors of the hydrolysis of Ac-Tyr-OEt by subtilisin and 
found a range of values from 30 to 340 mM. Also, Morihara 
et a_l. (1970) measured K m's of a series of synthetic di-, 
tri-, and tetrapeptide amides and found a range of 5.7 to 
80 mM (K m, in certain instances, is a binding constant for 
substrates, analogous to the binding constant for inhibi­
tors) . Furthermore, Kurachi, Powers and Wilcox (1971) 
placed a lower limit of about 8 mM for the K-j-'s of inhibition 
of Chymotrypsin A by peptide chloromethyl ketones. Since 
chymotrypsin and subtilisin are homologous proteases and 
are similar in their mode of reaction with peptide chloro­
methyl ketones, binding constants are likely to be in the 
same general range (Robertus et al., 1972). The range of 
defining K OBS cannot be conclusively determined. However, 
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inhibitor concentrations from Table I is .069 to 1.5 mM. 
Since the minimum previously determined K-j. value was 5.7 mM, 
it is likely that for these peptide chloromethyl ketones 
is greater than the inhibitor concentrations used and 
Thus is seems reasonable to assume that the second order 
rate constant (K Q B S/[I]) reflects both the influence of K-j. 
and k.. according to equation (18) . 
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CHAPTER IV 
Discussion 
Synthesis of Inhibitors 
The majority of the amino acid couplings were done 
via the mixed carboxylic anhydride procedure (Anderson et al., 
1952). Using this procedure, the carboxyl group of an amino 
acid residue is activated under anhydrous conditions by 
reaction with isobutylchloroformate (or isovaleryl chloride) 
to give the mixed anhydride intermediate (7). The anhydride 
is then reacted with the free amine of another residue 
giving the dipeptide £8). An example of this method is 
shown on the following page in the preparation of the leucine 
chloromethyl ketone, Ac-Ala-LeuCH-Cl. 
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O O 
CH o-C-NH-CH-C-0H + (CH 3) 2-CH-CH 2-0-C-Cl l3 , 
CH. 
0 N-
CH^ 
O 0 0 
II II II 
CH o-C-NH-CH-C-0-C-0-CH o-CH-(CH 0) 
I 
CH. 
2 w " V W i 3 ' 2 
( 7 ) 
0 
_ + II 
CI NH 0-CH-C-CH 0C1 3 j 2 
CH„ 
CH 
CH 3 CH 3 
0 0 0 
(8) 
CH--C-NH-CH-C-NH-CH-C-CH 0C1 
3
 I I 2 
CH- CH 0 3 i z 
.CH 
C H 3 C H 3 
Scheme 1 
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The carbonyl carbon atom of the mixed anhydride most suscep­
tible to attack by a nucleophile should be the one with the 
lowest electron density and least steric hindrance. Conse­
quently, in the example shown previously, attack occurred at 
the carbonyl of alanine giving the dipeptide as the product. 
The first objective in the synthetic work was the 
preparation of a tetrapeptide L-phenylalanine chloromethyl 
ketone. The scheme shown on the next page shows the syn­
thetic procedure used to obtain this compound (Ac-Gly-Gly-
Ala-PheCH 0Cl). 
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Z-PheCH 0Cl > Br" +H 0-PheCH 0Cl 2 HOAc ' 2 2 
(9) 
Ac^O 
Gly-Gly
 R Q ~ c ) Ac-Gly-Gly-OH 
(CH 3) 2CHCH 2C0C1 
and 
CH 3 
Ala-OBz 
Ac-Gly-Gly-Ala-OBz 
(10) 
H 2, Pd/C 
^ Ac-Gly-Gly-Ala-OH 
(CH 3) 2CHCH 2C0C1 
Ac-Gly-Gly-Ala-PheCH 2Cl 
(9) and (CH 3CH 2) 3N 
Scheme 2 
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The tripeptide ester (Ac-Gly-Gly-Ala-OBz, 10) was obtained 
in 60% yield via the mixed anhydride procedure using the iso-
valeryl chloride. No attempt was made to prepare this com­
pound using iso-butylchloroformate. On the other hand, the 
tetrapeptide chloroketone (Ac-Gly-Gly-Ala-PheCI^Cl, 11) was 
prepared using both of these reagents. The yield using iso-
butylchlorof ormate was 44% and no byproduct was isolated. 
However, using iso-valeryl chloride the yield of compound 
(11) was 30% and a significant amount (yield not determined) 
of iso-valeryl phenylalanine chloromethyl ketone (12) was 
obtained resulting from attack by the amine moiety of phenyl­
alanine chloromethyl ketone at the wrong carbonyl of the 
mixed anhydride as shown on the next page. 
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0 0 0 0 
II II II II 
CH 3-C-NH-CH 2-C-NH-CH 2-C-OH + (CH 3) 2CHCH 2CH 2C-C1 
O 
CH. 
nJ/ 
0 0 0 0 
II II 
CH 3C-NH-CH 2-C-NH-CH 2-C-0-C-CH 2CH(CH 3) 2 
Br~H + 2-PheCH 2Cl Et 3N 
V 
0 0 
(CH 3) 2CHCH 2-C-NH-CH-C-CH 2C1 
CH. 
(12) 
Scheme 3 
Compound (10) was also obtained in 44% yield using 
EEDQ. This procedure is shown schematically on the next page: 
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Ac-Gly-Gly-OH > Ac-Gly-Gly-Ala-OBz 
H 
OEt 
C0 2Et 
Ala-OBz 
DMF, RT, 30 hours 
Scheme 4 
The procedure and work-up were very simple but the yield 
was relatively low. No attempt was made to vary conditions 
in order to improve the yield. The preparation of compound 
(11) was also attempted via the EEDQ procedure, but no product 
was isolated. 
The key intermediate in the synthesis of the leucine 
chloromethyl ketones was L-leucine chloromethyl ketone 
hydrochloride obtained from the reaction of gaseous hydro­
chloric acid and t-butyloxycarbonyl-L-leucine diazoketone. 
The scheme for the preparation of Z-Gly-Gly-LeuCH 2Cl is 
shown on the next page. 
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CHQ 0 
I 3 II 
NH 9-CH-C-0H + CH,-C-0-C-N, v n ? a Q H ^ 
2 | 3 i 3 H 2 ' d i o x a n e 7 
CH 9 C H 3 
I 2 
CH 
CH 3 CH 3 
CH Q 0 0 
I 3 II II 
CH o-C-0-C-NH-CH-C-0H 
3 i i 
CH. CH. 
1. 
2. 
iso-butylchloroformate 
C H 2 N 2 E t 2 ° 
CH 
CH. CH. 
CH, 
I 3 
0 0 
II CH 0-C-0-C-NH-CH-C-CH 0-N 0 3 i I 2 2 
CH. CH. 
.CH 
CH. CH. 
HCI 
Et 20 
0 
HCI•NH 0-CH-C-CH 0-C1 2 j 2 
CH 
CH. CH. 
Z-Gly-Gly-OH, 
mixed anhydride 
> 
(iso-butylchloroformate) 
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0 0 0 0 
II II II I  
C^H C-CH 0-0-C-NH-CH 0-C-NH-CH 0-C-NH-CH-C-CH 0C1 
3 
Scheme 5 
An initial attempt was made to prepare the hydrobromide of 
leucine chloromethyl ketone by deblocking Z-LeuCR^Cl with 
HBr in acetic acid. All attempts failed and the hydrobromide 
was never isolated. 
The compound Ac-Phe-Gly-Gly-OEt was obtained by the 
mixed anhydride procedure analogous to those described above. 
The ester was hydrolyzed and a crude oil was isolated. Due 
to lack of time, no spectra were obtained on the oil, but 
the compound was believed to be the acid due to the release 
of C 0 2 when the oil was dissolved in a sodium bicarbonate 
solution. However, attempts to couple the acid with phenyl­
alanine chloromethyl ketone were unsuccessful and the 
synthesis was not completed. 
Structure and Reactivity of Inhibitors 
An x-ray crystallographic study of subtilisin inhib­
ited by four peptide chloromethyl ketones (Z-Ala-PheCH2Cl, 
Z-Ala-Gly-PheCH 9Cl, Z-Gly-Gly-PheCH-Cl, and Ac-Ala-Gly-
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PheC^Cl) has shown that these inhibitors are bound to the 
enzyme via a covalent linkage between the imidiazole ring 
of His-64 and the methylene group of the chloromethyl ketone 
moiety (Robertus et al., 1972). The benzyl group of the 
phenylalanine residue lies in a hydrophobic crevice and the 
longest inhibitor formed three hydrogen bonds with the 
enzyme, producing a 3-sheet structure with an extended 
segment of backbone chain in the enzyme consisting of resi­
dues Ser-125, Leu-126, and Gly-127. The study presented 
in this thesis was undertaken to determine whether the 
solution reactivity of a series of peptide chloromethyl 
ketones could be correlated with the crystal structures of 
these inhibited subtilisin derivatives and with kinetic 
data from recent experiments with polypeptide substrates 
(Morihara et al. 1969, 1970). 
The rate of irreversible reaction of a site specific 
inhibitor with an enzyme should depend upon the amount of 
enzyme-inhibitor complex present at equilibrium and the 
rate limiting reaction of the bound inhibitor with the 
enzyme to form the inactivated enzyme. The steric arrange­
ment of the inhibitor and enzyme in the complex and electron­
ic effects would certainly influence covalent bond formation. 
On the other hand, the dissociation constant K^ . of the E-I 
complex is determined primarily by an entropy effect. An 
increase in entropy occurs upon binding the inhibitor to 
the enzyme due to breaking up of some water structure around 
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the water separated inhibitor and enzyme relative to the 
E«I complex. A structural change in the inhibitor could 
effect the extent of binding to the enzyme (measured by K ^ ) , 
the stereoelectronic relationship between inhibitor and 
enzyme in the E-I complex (measured by k^) or both (Kurachi, 
Powers and Wilcox, 1972). Shaw and Glover (1970) have 
shown that for inhibition of trypsin with certain chloro­
methyl ketones, the affinity of the enzyme for the inhibitor 
is not necessarily related to the rapidity of inactivation. 
In this thesis, these two effects were not determined and 
due to the low inhibitor concentrations used, the second 
order rate constants ( K Q B S / [ I ] ) used in the discussion 
reflect the influence of both and k^. 
As proposed from the x-ray results, a binding scheme 
for one of the peptide chloromethyl ketones used in this 
study is shown in Figure 4. This illustration is based on 
the crystallographically determined model of subtilisin 
inhibited with Z-Ala-Gly-PheCH 2Cl. In the following dis­
cussion of the reactivity of various inhibitors in terms 
of this model, the notations previously described (Chapter 
I, Figure 2) for peptide binding subsites for proteolytic 
enzymes will be used. 
Examination of the data in Table I (Chapter III) shows 
that there is a spread of a factor of 651 between the least 
reactive inhibitor (Ac-Gly-PheCR^Cl) and the most reactive 
(Z-Gly-Gly-LeuCH 9Cl). In general, the larger the number 
Figure 4. Crystallographic Model of Subtilisin Inhibited 
with Z-Ala-Gly-PheCH 9Cl. 
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of positive interactions between a given inhibitor and the 
enzyme, the larger the second order rate constant. This 
phenomena has previously been observed with peptide amide 
substrates (Morihara et al. 1970) as shown by the relative 
rate constants below in Table 2. 
Table 2. Comparison of Relative Rates of Di- and Tetra-
peptides Inhibitors and Substrates. 
Kcat 
Z-Gly-Leu-NH 2 1.00 
Z-Ala-Gly-Gly-Leu-NH 2 86.78 
K 0 B S / [ I ] 
Ac-Ala-PheCH 2Cl 1.00 
Ac-Gly-Gly-Ala-PheCH 2Cl 24.73 
It has been known for some time that the primary 
specificity of subtilisin is determined by the residue at 
the P 1 subsite in an inhibitor or substrate, and subtilisin 
shows a preference for amino acid residues in this position 
with aromatic or apolar side chains of the L-configuration. 
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This observation is readily explained by the presence of a 
hydrophobic binding cleft at site . Although the proposed 
substrate binding model from the x-ray study was based 
exclusively upon experiments with a phenylalanine residue 
at P^, the authors postulated that an identical crystallo­
graphic model could be constructed with a leucine residue 
at P^. The following relative rates in Table 3 indicate 
that subtilisin shows a preference for leucine at P,. 
Table 3. Relative Rates of Inhibitors Indicating Preference 
for Leucine Residue at P^. 
Ac-Ala-LeuCH 2Cl (25) 
Ac-Ala-PheCH 2Cl (14) 
Z-Gly-Gly-LeuCH 2Cl (651) 
Z-Gly-Gly-PheCH 2Cl (416) 
Also, Morihara and Tsuzuki (1969) found that subtilisin 
showed a preference for leucine over phenylalanine at P^, 
as shown in Table 4. Future x-ray work on subtilisin 
inhibited with Z-Gly-Gly-LeuCH 2Cl is planned and will hope­
fully explain subtilisin 1s preference for leucine at P^. 
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Table 4. Relative Rates of Hydrolysis of Ester Substrates 
Indicating a Preference for Leucine Residue at P 
Kcat ( s e c " ^ 
Ac-Leu-OMe 57.5 
Ac-Phe-OMe 30.6 
A somewhat surprising result was that alanine at P^ 
showed a significant relative reaction rate. The relative 
rate of Ac-Ala-Ala-Pro-AlaCH 2Cl was 237. 
This apparent broad specificity at S 1 for these tri-
and tetra- peptide inhibitors is indicative of the importance 
of the other subsites (S 2-S 4) in binding. It would be of 
interest to determine the reactivity of a dipeptide inhibitor 
with alanine at P^ ^ in comparison with the other dipeptides 
listed in Table 1. 
Strong evidence supporting the postulation that the 
solution reactivity of peptide chloromethyl ketones and of 
substrates can be correlated with the crystallographically 
based model is the effect on reactivity that an alanine 
residue has at P 2 of a substrate or inhibitor. The K^^/[I] 
value of Ac-Ala-PheCH 2Cl is greater than Ac-Gly-PheCH 2Cl 
and Ac-Leu-PheCH 2Cl by a factor of about 13, although they 
have the same structure except for the P 9 residue. These 
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results agree beautifully with kinetic data of Morihara et 
al. (1970) on the hydrolysis of peptide substrates by subtil­
isin. A comparison of the relative rates of the inhibitor 
and amide substrates is shown in Table 5. 
Table 5. Comparison of Relative Rates of Inhibitors and 
Substrates with Alanine Residue at P 2. 
Kcat 
Z-Ala-LeuNH 2 (14.00) 
Z-Leu-LeuNH 2 (2.40) 
Z-Gly-LeuNH 2 (1.00) 
These observations are consistent with the crystallographic 
results which show that the methyl side chain of alanine at 
P 2 makes van der Waals contact with Leu-96 and the side chain 
of His-64. It was presumed that these contacts allow optimum 
orientation of the substrate in the active site region and 
a larger side chain at P 2 would disrupt this alignment, while 
glycine at this position would allow greater freedom of 
motion and hence retard proper alignment of the inhibitor. 
W [ I ] 
Ac-Ala-PheCH 2Cl (13.92) 
Ac-Leu-PheCH 2Cl (1.44) 
Ac-Gly-PheCH 2Cl (1.00) 
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The reason that leucine is slightly faster than gly­
cine at P 2 in the above series is not immediately obvious, 
and these results are apparently anomolous with the finding 
that Z-Gly-Gly-PheCH 2Cl reacts almost 200 times faster than 
Z-Gly-Leu-PheCH 2Cl. It is possible that retardation of 
alignment resulting from freedom of motion with glycine at 
P 2 in the dipeptide series, is cancelled due to extension 
of the peptide chain to and subsequent stabilization by 
the addition of two hydrogen bonds. On the other hand, the 
unfavorable steric interactions resulting from leucine at 
P 2 are neutralized to a much lesser degree by extension of 
the peptide chain. 
The P 3 ~ S 3 interaction involves two additional hydrogen 
bonds and as expected, the kinetic data in Table 1 indicates 
that tripeptides are better inhibitors than dipeptides. For 
example, extension of the dipeptide inhibitor Ac-Gly-PheCH 2Cl 
to Z-Gly-Gly-PheCH 2Cl or BOC-Ala-Gly-PheCH 2Cl increases the 
second order rate constant by a factor of over 400. Also, 
extension of Ac-Leu-PheCH 2Cl to Z-Gly-Leu-PheCH 2Cl increases 
K Q Bg/[I] by a factor of about 150. 
It is clear from the kinetic data of Morihara et al. 
(1970) that subsite exerts an influence on substrate-
enzyme reaction. These authors found that the tetrapeptide 
substrate Z-Ala-Gly-Gly-LeuNH 2 was hydrolyzed over 2.5 times 
faster than the tripeptide substrate Z-Gly-Gly-LeuNH 2. Very 
little can be said about S. from the x-ray results since a 
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tetrapeptide was not studied. A benzyloxycarbonyl or acetyl 
blocking group was located at and determination of the 
exact location of these groups was hindered for reasons 
which will not be discussed. However, the electron density 
maps from the enzyme inhibited with Z-Ala-PheCH 2Cl showed 
that a large depression in the sirface of the enzyme existed 
in the vicinity of S 4 which could possibly represent a 
second hydrophobic crevice for binding P 4 residues. This 
suggests that S 4 may be designed with structural specifi­
cations similar to S^. The data in Table 1 shows that the 
fastest inhibitors are Z-Gly-Gly-LeuCH 2Cl, Z-Gly-Gly-PheCH 2Cl, 
and BOC-Ala-Gly-PheCH 2Cl. All have aromatic or apolar systems 
at P^. Although these are not amino acid residues, it is 
possible that good binding occurs due to the P^-S^ inter­
actions described above. These three inhibitors are faster 
than the tetrapeptide Ac-Gly-Gly-Ala-PheCH 2Cl. Replacement 
of the BOC groupd in BOC-Ala-Gly-PheCH 2Cl with an acetyl 
group decreases the second order rate constant approximately 
38 percent. 
Crystallographic work is planned on subtilisin in­
hibited with Ac-Gly-Gly-Ala-PheCH 2Cl which should give 
indication of the interaction at with an amino acid 
residue at P 4. Also, synthesis of a tetrapeptide with a 
phenylalanine residue at P 4 has been started to determine 
the effect of an aromatic side chain in the postulated 
hydrophobic cavity at S.. 
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In conclusion, the kinetic results presented in this 
thesis are consistent with the model illustrated in Figure 
4 and show that the magnitude of the second order rate con­
stant KQgg/t 1] is dependent on the number of positive inter­
actions between the enzyme and inhibitor. These rates are 
also correlated with substrate specificity of subtilisin and 
support the hypothesis that the productive binding mode of 
this enzyme with chloromethyl ketone inhibitors which leads 
to alkylation of His-64 is similar to the productive binding 
mode of substrates leading to acylation of Ser-221. 
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CHAPTER V 
RECOMMENDATIONS 
The structure analysis by x-ray of Ac-Gly-Gly-Ala-
PheCH 2Cl would provide exact information regarding inter­
actions at the fourth subsite; this work is planned in the 
near future. Also, an x-ray study on Z-Gly-Gly-LeuCH^Cl is 
planned to observe interactions in the S 1 subsite with a 
leucine residue at p^. 
The synthesis of Ac-Phe-Gly-Gly-PheCH 2Cl or Ac-Phe-
Gly-Gly-LeuCH 2Cl has been started in order to observe via 
crystallography possible hydrophobic interactions at S 4 with 
the phenylalanine side chain at P 4. 
A kinetic study to determine the variation in the 
ratio K Q B S / [ I ] with inhibitor concentration would provide 
information for determining the exact equation defining the 
pseudo first order rate constants, K Q B S , obtained in this 
thesis. 
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